19.02.2013 Views

4th EucheMs chemistry congress

4th EucheMs chemistry congress

4th EucheMs chemistry congress

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Poster Session 2<br />

s1244<br />

chem. Listy 106, s257–s1425 (2012)<br />

Poster session 2 - Nano<strong>chemistry</strong>, Nanotechnology<br />

P - 0 7 6 3<br />

hiGh-LeveL GeoMetriC ControL of new<br />

rotAMeriC MoLeCuLAr CLiP reCePtorS: nMr<br />

StudieS of rotAMer interConverSion And<br />

BindinG to dihydroxyBenzene GueStS<br />

B. MurrAy 1 , B. CreAven 1 , M. Kozien 1 , J. MorAn 1 ,<br />

z. yeASMin 1<br />

1 Institute of Technology Tallaght, Science, Dublin 24, Ireland<br />

Molecular clips, originally introduced by Nolte [1] , are<br />

well-known artificial receptors for dihydroxyaromatics, e.g.<br />

resorcinol, catechol, catecholamines, and other biomolecules<br />

bearing a dihydroxyaromatic unit. Two xylylene walls and two<br />

carbonyl groups, making a pre-organized cavity, are the key<br />

features which bind the substrate via two aryl-stacking & two<br />

hydrogen-bonding interactions. [1]<br />

We have prepared new clips which exist as rotamers:<br />

isomers interconverted by rotation about a single bond. [2] The<br />

rotameric site is incorporated into two phenyl substituents which<br />

control the convergent conformation of the receptor, but do not<br />

directly disturb the binding site.<br />

VT-NMR allows us to interconvert these rotamers, and<br />

measure the energy barrier; the latter is also accessible via free<br />

energy calculations. Surprisingly, the energy barrier was found to<br />

be independent of the nature of the substituent in the<br />

3,3'-positions, but this has now allowed us rationalize the<br />

mechanism of interconversion.<br />

We have now moved on to a more hindered<br />

2,2'-disubstituted series, where variation of the substituent now<br />

allows a significant biasing towards the trans-rotamer being more<br />

stable (up to 100%), and also leads to higher interconversion<br />

barriers.<br />

NMR titration yields binding constants to guests such as<br />

resorcinol.<br />

The new rotameric clips show considerable promise for<br />

high-level control of receptor geometry and of associated binding<br />

of guests to each rotamer.<br />

references:<br />

1. a) Sijbesma, R. P.; Wijmenga, S. S.; Nolte, R. J. M. J. Am.<br />

Chem. Soc. 1992, 114, 9807;<br />

b) Sijbesma, R. P.; Bosman, W. P.; Nolte, R. J. M. J. Org.<br />

Chem. 1991, 56, 3199;<br />

c) Smeets, J. W. H.; van Dalen, L.; Kaats-Richter,<br />

V. E. M.; Nolte, R. J. M. J. Org. Chem. 1990, 55, 454.<br />

2. Kozien, M. PhD Thesis, ITT Dublin, 2009.<br />

Keywords: Molecular recognition; NMR spectroscopy;<br />

Isomerization; Atropisomerism; Host-guest systems;<br />

4 th <strong>EucheMs</strong> <strong>chemistry</strong> <strong>congress</strong><br />

P - 0 7 6 4<br />

nAnoPArtiCuLAte AeroSoL MAnufACturinG<br />

ProCeSS<br />

f. nALBAntoGLu 1 , M. ozBeK 2 , e. er 2 , o. KArBAn 2 ,<br />

G. KAynAr 2 , M. KArABuLut 2 , t. ozden 1<br />

1 Gazi University Faculty of Pharmacy, Pharmaceutical<br />

Chemistry, Ankara, Turkey<br />

2 World Medicine pharmaceuticals, R&D, Istanbul, Turkey<br />

Micronised drug particles for MDI products of aerosol<br />

asthma drugs on the market tends to be acculumated on the inner<br />

surface of containers, or valve components during their shelf lifes.<br />

These micronised particles can also undergo moisture initiated<br />

instability where water can promote chemical instability and<br />

particle adhesion/cohesion differences in these formulations.<br />

While we were devoloping a new aerosol formulation,<br />

suprisingly, we founded that if the formulation have specific<br />

parameters in terms of particles size distribution rate or<br />

morphology which affects obtainable surface area and moisture<br />

absorbtion profiles, the resulted formulation have greater<br />

suspension stability in its life-time use while comparing its former<br />

specifications.<br />

The formulation must be a nanoparticulate pharmaceutical<br />

composition -solid concentration between 0.1 % – 0.5 %- at least<br />

one active pharmaceutical ingredient or salt or solvate, at least<br />

one propellant or propellant mixture, at least one polymer or<br />

polymer combination which has moleculer weight of<br />

190-70000 g/mol.<br />

Formulation trials have been done for these nanoparticulate<br />

aerosol formulations in order to obtain desired particle size and<br />

morphology which are < 0.5 μm and spherical, respectively.<br />

Sample concentrations were used in 2.5 % – 5 % (as weight basis).<br />

Solution or suspension were prepared in water and mixed by<br />

mechanical mixer before spraying through the nozzles. Nano<br />

spray-drying method encapsulates successfully active ingredient<br />

with polymer/ polymer combinations which increases the<br />

moisture and gas barrier properties while increasing surface area<br />

of dispersed particles in liquefied gas. This leads to improvements<br />

on the chemical instability resulted from the moisture in the<br />

structure and more cohesive forces which enhances the uniformity<br />

of the composition. Active ingredient were mixed with polymer<br />

or polymer combinations in different ratios. A yield of 70-75% is<br />

attained with the use of spheric particles with the size between<br />

0,6 and 4 micron.<br />

Keywords: nanoparticles; Drug delivery; Polymers;<br />

Nanotechnology;<br />

AUGUst 26–30, 2012, PrAGUE, cZEcH rEPUbLIc

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!